EFFICACY OF TENAPANOR AS A PHOSPHATE-LOWERING THERAPY IN PATIENTS WITH END-STAGE KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS

https://storage.unitedwebnetwork.com/files/1099/e046b8c655bee2286657c2fb86948e60.pdf
EFFICACY OF TENAPANOR AS A PHOSPHATE-LOWERING THERAPY IN PATIENTS WITH END-STAGE KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
Maria Gabriela
Guimarães
Fernanda Tapioca fernandapmartin@hotmail.com Hospital Ana Nery Nephrology and Dialysis Salvador
Nicole Felix nicole.santos@estudante.ufcg.edu.br Federal University of Campina Grande Medical School Campina Grande
Naiara Dos Santos n.rodriguesdossantos@yahoo.com.br Hospital Ana Nery Nephrology and Dialysis Salvador
Fernanda Ferreira fernandapctf@gmail.com Hospital Ana Nery Nephrology and Dialysis Salvador
Carolina Neves nevesc200@gmail.com Hospital Ana Nery Nephrology and Dialysis Salvador
Rosélia Lobão rslobao@uol.com.br Hospital Ana Nery Nephrology and Dialysis Salvador